Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpel Priv Eqty Regulatory News (JPEL)

Share Price Information for Jpel Priv Eqty (JPEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.89
Bid: 0.86
Ask: 0.92
Change: 0.00 (0.00%)
Spread: 0.06 (6.977%)
Open: 0.89
High: 0.89
Low: 0.89
Prev. Close: 0.89
JPEL Live PriceLast checked at -
JPEL Private Equity is an Investment Trust

To effect an orderly realisation of the investments and other assets comprised in the portfolio of the company and will seek to realise such investments and assets in order to maximise returns to US equity shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Credit Facility Refinance - January 2011

10 Mar 2011 07:00

RNS Number : 6425C
J.P. Morgan Private Equity Ltd
10 March 2011
 



 

 

 

JPEL ANNOUNCES $150 Million MULTI-CURRENCYCREDIT FACILITY WITH LLOYDS BANK CORPORATE MARKETS

 

 

* * *

 

GUERNSEY, 10 MARCH 2011

 

J.P. Morgan Private Equity Limited ("JPEL" or the "Company") is pleased to announce that it has reached agreement on the terms of a new multi-currency credit facility in the amount of US$150 million with Lloyds Bank Corporate Markets.

 

Proceeds from the new facility will be used to refinance the Company's existing $100 million facility with Fortress Credit Corp, which is scheduled to mature in 2012.

 

The Lloyds Bank Corporate Markets facility offers the Company multi-currency flexibility, improved pricing and a longer maturity date of May 2013. Key terms of the facility include:

 

·; LIBOR +275bps for a loan to value ratio (LTV) of less than or equal to 10%, with no LIBOR floor

·; LIBOR +325bps for a LTV ratio of greater than 10%, with no LIBOR floor

 

The Company believes that this larger, multi-currency facility will better support JPEL as it seeks to capitalize on opportunities within the secondary private equity markets and grow assets under management.

 

"We are pleased to expand our relationship with Lloyds Bank Corporate Markets. This new facility provides a meaningful reduction in debt service costs and significantly enhances JPEL's financial flexibility to support its overall strategic initiatives" said Trevor Ash, JPEL's Chairman.

 

Robina Barker Bennett, Global Head of Funds, Lloyds Bank Corporate Markets added, "We place great value on our long-standing relationship with JPEL and are pleased to be able to provide the Company with the financing it needs in the context of its growth aspirations."

 

"Refinancing the existing credit facility is an important milestone for JPEL. The Directors believe that the refinancing will benefit the Company," added Trevor Ash.

 

* * *

 

About J.P. Morgan Private Equity Limited

 

J.P. Morgan Private Equity Limited is a Guernsey registered and incorporated, London Stock Exchange-listed, closed-ended investment company (LSE: JPEL, JPEZ, JPZZ) designed primarily to invest in the global private equity market. The investment objective of the Company is to achieve both short and long-term capital appreciation by investing in a well diversified portfolio of private equity fund interests and by capitalising on the inefficiencies of the secondary private equity market. On 17 August 2009, JPEL issued warrants free of subscription cost to shareholders on record. The warrants are publicly traded on the London Stock Exchange under the symbol "JPWW."

 

END

For further information please contact:

 

J.P. Morgan Private Equity Limited

Troy Duncan / Greg Getschow

+44 (0)20 7742 9203 / +1 212 648 1150

Troy.duncan@jpmorgan.com / Gregory.getschow@jpmorgan.com

 

Peregrine Communications

Anthony Payne / Max Hilton

+44 203 178 6869

anthony.payne@peregrinecommunications.com / max.hilton@peregrinecommunications.com

 

For Lloyds Bank Corporate Markets

Louise Riordan

Financial Dynamics

+ 44 (0)20 7269 9308 / 07515 597 556

louise.riordan@fd.com

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCMMGGFKLVGMZM
Date   Source Headline
15th Nov 20195:52 pmRNSNet Asset Value(s) - September
15th Nov 20195:51 pmRNSNet Asset Value(s) - August 2019
15th Nov 20195:51 pmRNSNet Asset Value(s) - July 2019
5th Nov 20195:42 pmRNS2019 AGM CIRCULAR
22nd Oct 20197:00 amRNSCompletion of Sixth Mandatory Redemption
9th Oct 20193:28 pmRNSSixth Mandatory Redemption
27th Sep 201910:48 amRNSAnnual Financial Report - 30 June 2019
10th Sep 20191:19 pmRNSNet Asset Value(s) - June 2019
12th Jul 20197:00 amRNSNet Asset Value(s) - May 2019
13th Jun 20197:00 amRNSNet Asset Value(s) - April 2019
17th May 20197:00 amRNSNet Asset Value(s) - March 2019
5th Apr 20197:00 amRNSNet Asset Value(s) - February 2019
19th Mar 20193:57 pmRNSHalf-year Report - 31 December 2018
13th Mar 20197:00 amRNSNet Asset Value(s)
7th Feb 201910:55 amRNSNet Asset Value(s) - December 2018
22nd Jan 201910:10 amRNSNet Asset Value(s) - November 2018
8th Jan 20197:00 amRNSCompletion Of Fifth Mandatory Redemption
10th Dec 20183:58 pmRNSMandatory Redemption - US$Equity Shares - Dec 2018
6th Dec 20183:28 pmRNSHolding(s) in Company
30th Nov 20183:21 pmRNSNet Asset Value(s) - October 2018
27th Nov 201811:08 amRNSAGM Results 2018
7th Nov 20187:00 amRNS2018 AGM CIRCULAR
30th Oct 20187:00 amRNSNet Asset Value(s) - August 2018
30th Oct 20187:00 amRNSNet Asset Value(s) - September 2018
30th Oct 20187:00 amRNSNet Asset Value(s) - July 2018
12th Oct 20184:32 pmRNSHolding(s) in Company
4th Oct 20182:42 pmRNSNotification of Dealings in Shares
28th Sep 20181:10 pmRNSAnnual Financial Report - 30 June 2018
17th Sep 20187:00 amRNSNet Asset Value(s) - June 2018
22nd Aug 20185:11 pmRNSHolding(s) in Company
20th Jul 20187:00 amRNSNet Asset Value(s) - May 2018
3rd Jul 20187:00 amRNSNet Asset Value(s) - April 2018
9th May 20187:00 amRNSNet Asset Value(s) - March 2018
13th Apr 20189:30 amRNSNet Asset Value(s) - February 2018
11th Apr 20187:00 amRNSNotice to Shareholders - Total Voting Rights
10th Apr 20182:24 pmRNSCompletion of Fourth Mandatory Redemption
22nd Mar 20187:00 amRNSHalf-year Report - 31 December 2017
22nd Mar 20187:00 amRNSMandatory Redemption- US$Equity Shares -April 2018
12th Mar 20187:00 amRNSNet Asset Value(s) - January 2018
2nd Feb 20187:00 amRNSNet Asset Value(s) - December 2017
15th Jan 20187:00 amRNSNet Asset Value(s) - November 2017
29th Dec 20171:15 pmRNSNotice to Shareholders - Key Information Document
14th Dec 20175:50 pmRNSNotice to Shareholders - Total Voting Rights
14th Dec 20177:00 amRNSCompletion Of Third Mandatory Redemption
4th Dec 20172:52 pmRNSAGM Results
4th Dec 20179:44 amRNSNet Asset Value(s) - October 2017 Review
1st Dec 20177:05 amRNSMandatory Redemption - US$Equity Shares - Dec 2017
1st Dec 20177:00 amRNSNet Asset Value(s) - October 2017
24th Nov 20177:00 amRNSSale of Celerion
20th Nov 20172:59 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.